Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2025-12-24 @ 11:10 PM
NCT ID:
NCT05834569
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 65 years or older undergoing minimally invasive lung lobectomy or segmentectomy
Exclusion Criteria:
* Hypersensitivity to the main ingredients and additives of Maxigesic
* Hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs)
* Alcoholism / Alcohol intoxication
* Severe hematological abnormalities
* Bleeding tendency (e.g., Spontaneous bleeding)
* Severe hepatic dysfunction (AST, AST ≥2.5 \* upper normal limit(UNL) or Total bilirubin ≥3.0 mg/dl)
* Severe renal dysfunction (eGFR \<30 ml/min/1.73m2 or Dialysis)
* Severe heart failure (Left ventricle ejection fraction \<30%)
* Uncontrolled hypertension(HTN) (Systolic blood pressure \>180 mmHg)
* Symptomatic asthma in need of treatment
* Anticoagulants or antiplatelet agents are maintained for up to 5 days before surgery
* Barbiturates or tricyclic antidepressants (TCAs)
* High-dose methotrexate (MTX) for cancer treatment
* Preoperative cognitive impairment, dementia, or delirium
* Inability to understand the research and instructions for this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT05834569
Study Brief:
Protocol Section:
NCT05834569